Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
200.7 USD | -0.62% | -3.09% | -11.67% |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.67% | 16.99B | B | ||
+15.08% | 83.02B | C+ | ||
+11.06% | 29.97B | C+ | ||
-5.56% | 15.93B | A- | ||
-7.76% | 14.15B | A- | ||
-0.10% | 12.08B | A- | ||
-30.35% | 11.8B | - | - | |
+21.91% | 11.38B | B- | ||
-6.38% | 10.91B | A- | ||
+44.22% | 10.91B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LH Stock
- Ratings Laboratory Corporation of America Holdings